![Laura Bessen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laura Bessen
Director/Board Member at
C4 THERAPEUTICS, INC.
Net worth: - $ as of 29/06/2026
Profile
Laura Bessen is currently an Independent Director at C4 Therapeutics, Inc. since 2022.
Formerly, Dr. Bessen was an Independent Director at Artiva Biotherapeutics, Inc. from 2022 to 2025 and served as Vice President & Head-US Medical at Bristol Myers Squibb Co. from 2001 to 2016.
Education includes undergraduate studies at the State University of New York at Binghamton and a doctorate from New York University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 23/06/2026 | 0 ( -.--% ) | - $ | 29/06/2026 |
Laura Bessen active positions
| Companies | Position | Start |
|---|---|---|
| C4 THERAPEUTICS, INC. | Director/Board Member | 31/07/2022 |
Former positions of Laura Bessen
| Companies | Position | End |
|---|---|---|
| ARTIVA BIOTHERAPEUTICS, INC. | Director/Board Member | 23/06/2025 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/12/2015 |
Training of Laura Bessen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
92
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
- Stock Market
- Insiders
- Laura Bessen
